Skip to main content
Marc Halushka, MD, Pathology, Cleveland, OH

MarcKennethHalushkaMDPhD

Pathology Cleveland, OH

Anatomic Pathology, Clinical Pathology

Associate Professor of Pathology, Associate Professor of Oncology, Johns Hopkins University School of Medicine; Director, Oncology Tissue Services (formerly the Tissue Microarray Core)

Dr. Halushka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Halushka's full profile

Already have an account?

  • Office

    9500 Euclid Ave
    L25
    Cleveland, OH 44195
    Phone+1 216-444-2824

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2001 - 2004
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 2001

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2004 - 2026
  • OH State Medical License
    OH State Medical License 2023 - 2025
  • FL State Medical License
    FL State Medical License 2017 - 2019
  • American Board of Pathology Anatomic Pathology

Publications & Presentations

PubMed

Journal Articles

  • miRNA Regulation in Gliomas: Usual Suspects in Glial Tumorigenesis and Evolving Clinical Applications  
    Heather Ames, Fausto J. Rodriguez, Marc K. Halushka, Journal of Neuropathology & Experimental Neurology

Press Mentions

  • Research News Tip Sheet: Story Ideas from Johns Hopkins Medicine
    Research News Tip Sheet: Story Ideas from Johns Hopkins MedicineNovember 17th, 2020
  • Myocarditis May Be Less Common Among COVID-19 Patients Than Previously Believed
    Myocarditis May Be Less Common Among COVID-19 Patients Than Previously BelievedOctober 30th, 2020
  • An Orally Bioavailable Small-Molecule Inhibitor of Hedgehog Signaling Inhibits Tumor Initiation and Metastasis in Pancreatic Cancer
    An Orally Bioavailable Small-Molecule Inhibitor of Hedgehog Signaling Inhibits Tumor Initiation and Metastasis in Pancreatic CancerSeptember 15th, 2008